Back to GetFilings.com



UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE
SECURITIES EXCHANGE ACT OF 1934

For The Quarterly Period Ended May 28, 2005

OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE
SECURITIES EXCHANGE ACT OF 1934

For The Transition Period From           To           

Commission File Number 1-5742

RITE AID CORPORATION

(Exact name of registrant as specified in its charter)


Delaware 23-1614034
(State or Other Jurisdiction of
Incorporation or Organization)
(I.R.S. Employer
Identification No.)
   
30 Hunter Lane,
Camp Hill, Pennsylvania
(Address of Principal Executive Offices)
    
17011
(Zip Code)

Registrant's Telephone Number, Including Area Code: (717) 761-2633

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report) Not Applicable

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes [X] No [ ]

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

The registrant had 520,952,399 shares of its $1.00 par value common stock outstanding as of June 22, 2005.




RITE AID CORPORATION

TABLE OF CONTENTS


    Page
  Cautionary Statement Regarding Forward Looking Statements   3  
PART I
FINANCIAL INFORMATION
ITEM 1. Financial Statements (unaudited):      
  Condensed Consolidated Balance Sheets as of May 28, 2005 and
February 26, 2005
  4  
  Condensed Consolidated Statements of Operations for the Thirteen Week Periods
Ended May 28, 2005 and May 29, 2004
  5  
  Condensed Consolidated Statements of Cash Flows for the Thirteen Week Periods
Ended May 28, 2005 and May 29, 2004
  6  
  Notes to Condensed Consolidated Financial Statements   7  
ITEM 2. Management's Discussion and Analysis of Financial Condition and
Results of Operations
  16  
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk   23  
ITEM 4. Controls and Procedures   23  
PART II
OTHER INFORMATION
 
ITEM 1. Legal Proceedings   24  
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds   24  
ITEM 3. Defaults Upon Senior Securities   24  
ITEM 4. Submission of Matters to a Vote of Security Holders   24  
ITEM 5. Other Information   24  
ITEM 6. Exhibits   24  
         
         

2




CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This report includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are identified by terms and phrases such as "anticipate," "believe," "intend," "estimate," "expect," "continue," "should," "could," "may," "plan," "project," "predict," "will" and similar expressions and include references to assumptions and relate to our future prospects, developments and business strategies.

Factors that could cause actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to:

•  our high level of indebtedness;
•  our ability to make interest and principal payments on our debt and satisfy the other covenants contained in our senior secured credit facility and other debt agreements;
•  our ability to improve the operating performance of our existing stores in accordance with our long term strategy;
•  our ability to hire and retain pharmacists and other store personnel;
•  our ability to open or relocate stores according to our real estate development program;
•  the outcomes of pending lawsuits and governmental investigations;
•  competitive pricing pressures and continued consolidation of the drugstore industry; and
•  the efforts of third-party payors to reduce prescription drug reimbursements and encourage mail order, changes in state or federal legislation or regulations, the success of planned advertising and merchandising strategies, general economic conditions and inflation, interest rate movements, access to capital, and our relationships with our suppliers.

We undertake no obligation to revise the forward-looking statements included in this report to reflect any future events or circumstances. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements. Factors that could cause or contribute to such differences are discussed in the section entitled "Management's Discussion and Analysis of Financial Condition and Results of Operations—Overview and Factors Affecting Our Future Prospects" included in our Annual Report on Form 10-K for the fiscal year ended February 26, 2005 ("the Fiscal 2005 10-K"), which we filed with the Securities and Exchange Commission ("SEC") on April 29, 2005 and is available on the SEC's website at www.sec.gov.

3




PART I. FINANCIAL INFORMATION

ITEM 1.    Financial Statements

RITE AID CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share amounts)
(unaudited)


  May 28,
2005
February 26,
2005
ASSETS            
Current assets:            
Cash and cash equivalents $ 135,037   $ 162,821  
Accounts receivable, net   461,137     483,455  
Inventories, net   2,325,488     2,310,153  
Prepaid expenses and other current assets   52,546     50,325  
Total current assets   2,974,208     3,006,754  
Property, plant and equipment, net   1,701,383     1,733,694  
Goodwill   684,535     684,535  
Other intangibles, net   177,085     179,480  
Other assets   310,346     328,120  
Total assets $ 5,847,557   $ 5,932,583  
LIABILITIES AND STOCKHOLDERS' EQUITY                  
Current liabilities:                  
Current maturities of long-term debt and lease financing obligations $ 52,258   $ 223,815  
Accounts payable   782,944     757,571  
Accrued salaries, wages and other current liabilities   714,367     690,351  
Total current liabilities   1,549,569     1,671,737  
Convertible notes   247,875     247,500  
Long-term debt, less current maturities   2,681,530     2,680,998  
Lease financing obligations, less current maturities   165,653     159,023  
Other noncurrent liabilities   842,061     850,391  
Total liabilities   5,486,688     5,609,649  
Commitments and contingencies        
Stockholders' equity:            
Preferred stock – series E, par value $1 per share; liquidation value $50 per share   120,000     120,000  
Preferred stock – series F, par value $1 per share; liquidation value $100 per share   115,343     113,081  
Preferred stock – series G, par value $1 per share; liquidation value $100 per share   115,060     113,081  
Preferred stock – series H, par value $1 per share; liquidation value $100 per share   114,777     113,081  
Common stock, par value $1 per share   520,903     520,438  
Additional paid-in capital   3,119,513     3,121,404  
Accumulated deficit   (3,722,722   (3,756,146
Accumulated other comprehensive loss   (22,005   (22,005
Total stockholders' equity   360,869     322,934  
Total liabilities and stockholders' equity $ 5,847,557   $ 5,932,583  
             
             

See accompanying notes to condensed consolidated financial statements.

4




RITE AID CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(unaudited)


  Thirteen Week Period Ended
  May 28,
2005
May 29,
2004
Revenues $ 4,221,436   $ 4,244,357  
Costs and expenses:               
Cost of goods sold, including occupancy costs   3,140,803     3,191,456  
Selling, general and administrative expenses   947,453     912,845  
Store closing and impairment charges (credits)   15,532     (4,595
Interest expense   70,851     77,801  
Gain on sale of assets and investments, net   (538   (1,918
    4,174,101     4,175,589  
Income before income taxes   47,335     68,768  
Income tax expense   13,911     5,049  
Net income $ 33,424   $ 63,719  
Computation of income applicable to common stockholders:               
Net income $ 33,424   $ 63,719  
Accretion of redeemable preferred stock   (26   (26
Cumulative preferred stock dividends   (8,149   (8,356
Income attributable to common stockholders $ 25,249   $ 55,337  
Basic and diluted income per share:               
Basic income per share $ 0.05   $ 0.11  
Diluted income per share $ 0.05   $ 0.10  

See accompanying notes to condensed consolidated financial statements.

5




RITE AID CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(unaudited)


  Thirteen Week Period Ended
  May 28,
2005
May 29,
2004
Operating activities:            
Net income $ 33,424   $ 63,719  
Adjustments to reconcile to net cash provided by operations:            
Depreciation and amortization   60,330     63,192  
Stock-based compensation expense   4,890     3,982  
Store closing and impairment charges (credits)   15,532     (4,595
Gain on sale of assets and investments, net   (538   (1,918
Changes in income tax receivables and payables   20,030     41,279  
Changes in operating assets and liabilities   39,172     50,900  
Net cash provided by operating activities   172,840     216,559  
Investing activities:            
Expenditures for property, plant and equipment   (41,795   (35,088
Intangible assets acquired   (7,922   (6,730
Proceeds from sale-leaseback transaction   18,784      
Proceeds from dispositions   8,787     3,483  
Net cash used in investing activities   (22,146   (38,335
Financing activities:            
Principal payments on long-term debt   (172,955   (6,162
Principal payments on senior secured credit facility   (1,125    
Proceeds from financing secured by owned property   5,352      
Change in zero balance cash accounts   (9,219   (8,586
Proceeds from issuance of common stock   1,885     1,920  
Payments for preferred stock dividends   (2,212    
Deferred financing costs paid   (204    
Net cash used in financing activities   (178,478   (12,828
(Decrease) increase in cash and cash equivalents   (27,784   165,396  
Cash and cash equivalents at beginning of period   162,821     334,755  
Cash and cash equivalents at end of period $ 135,037   $ 500,151  
Supplementary cash flow data:            
Cash paid for interest (net of capitalized amounts of $134 and $44) $ 43,501   $ 52,152  
Cash refunds of income taxes, net $ (5,882 $ (35,982
Equipment financed under capital leases $ 1,300   $ 4,068  
Equipment received for non-cash consideration $   $ 204  

See accompanying notes to condensed consolidated financial statements.

6




RITE AID CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Thirteen Week Periods Ended May 28, 2005 and May 29, 2004
(Dollars and share information in thousands, except per share amounts)
(unaudited)

1.    Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X and therefore do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete annual financial statements. The accompanying financial information reflects all adjustments (consisting primarily of normal recurring adjustments except as described in these notes) which are, in the opinion of management, necessary for a fair presentation of the results for the interim periods. The results of operations for the thirteen week period ended May 28, 2005 are not necessarily indicative of the results to be expected for the full year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Fiscal 2005 10-K.

2.    Recent Accounting Pronouncements

In December 2004, the Financial Accounting Standards Board ("FASB") issued SFAS No. 123R, "Shared-Based Payment". This Standard requires companies to account for share-based payments to associates using the fair value method of expense recognition. This standard is required to be adopted as of the first fiscal year beginning after June 15, 2005. The Company has not yet adopted SFAS No. 123R. However, as the Company has adopted the fair value recognition provisions of SFAS No. 123, the Company does not expect the adoption of SFAS No. 123R to have a material impact on its financial position or results of operations.

In March 2005, the FASB issued Interpretation No. 47 ("FIN 47"), "Accounting for Conditional Asset Retirement Obligations – an interpretation of FASB Statement No. 143". FIN 47 requires an entity to recognize a liability for the fair value of a conditional asset retirement obligation if the fair value can be reasonably estimated. FIN 47 states that a conditional asset retirement obligation is a legal obligation to perform an asset retirement activity in which the timing or method of settlement are conditional upon a future event that may or may not be within control of the entity. FIN 47 is effective no later than the end of fiscal years ending after December 15, 2005. Retrospective application for the interim financial information is permitted but not required. Early adoption of FIN 47 is encouraged. The Company has not quantified the impact of adopting FIN 47, but does not expect the adoption to have a material impact on its financial position or results of operations.

7




RITE AID CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
For the Thirteen Week Periods Ended May 28, 2005 and May 29, 2004
(Dollars and share information in thousands, except per share amounts)
(unaudited)

3.    Income Per Share

Following is a summary of the components of the numerator and denominator of the basic and diluted income per share computation:


  Thirteen Week Period Ended
  May 28,
2005
May 29,
2004
Numerator for income per share:                  
Net income $ 33,424   $ 63,719  
Accretion of redeemable preferred stock   (26   (26
Cumulative preferred stock dividends   (8,149   (8,356
Income attributable to common stockholders – basic $ 25,249   $ 55,337  
Plus: Interest on convertible debt $   $ 2,968  
Income attributable to common shareholders – diluted $ 25,249   $ 58,305  
Denominator:                  
Basic weighted average shares   520,752     516,837  
Outstanding options   8,932     18,792  
Convertible debt       38,462  
Diluted weighted average shares   529,684     574,091  
Basic and diluted income per share:                     
Basic income per share $ 0.05   $ 0.11  
Diluted income per share $ 0.05   $ 0.10  

Due to their antidilutive effect, the following potential common shares have been excluded from the computation of diluted earnings per share:


  Thirteen Week Period Ended
  May 28,
2005
May 29,
2004
Stock options   36,605     14,802  
Convertible preferred stock   95,655     77,484  
Convertible debt   38,462      
    170,722     92,286  

4.    Store Closing and Impairment Charges

Store closing and impairment charges (credits) consist of:


  Thirteen Week Period Ended
  May 28,
2005
May 29,
2004
Impairment charges $ 3,457   $ 829  
Store and equipment lease exit charges (credits)   12,075     (5,424
  $ 15,532   $ (4,595

8




RITE AID CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
For the Thirteen Week Periods Ended May 28, 2005 and May 29, 2004
(Dollars and share information in thousands, except per share amounts)
(unaudited)

Impairment charges

Impairment charges include non-cash charges of $3,457 and $829 for the thirteen week periods ended May 28, 2005 and May 29, 2004, respectively, for the impairment of long-lived assets at 18 and 11 stores, in the respective periods. These amounts include the write-down of long-lived assets at stores that were assessed for impairment because of management's intention to relocate or close the store.

Store and equipment lease exit charges (credits)

During the thirteen week periods ended May 28, 2005 and May 29, 2004, the Company recorded charges for five closed stores and one closed store in the respective periods. Charges to close a store, which principally consist of lease termination costs, are recorded at the time the store is closed and all inventory is liquidated, pursuant to the guidance set forth in SFAS No. 146, "Accounting for Costs Associated with Exit or Disposal Activities". The Company calculates its liability for closed stores on a store-by-store basis. The calculation includes future minimum lease payments and related ancillary costs, from the date of closure to the end of the remaining lease term, net of estimated cost recoveries that may be achieved through subletting properties or through favorable lease terminations. This liability is discounted using a risk-free rate of interest. The Company evaluates these assumptions each quarter and adjusts the liability accordingly. The amounts of the closed store charges that relate to new closures, changes in assumptions, and interest accretion are presented in the following table.

The reserve for store and equipment lease exit costs includes the following activity:


  Thirteen Week Period Ended
  May 28,
2005
May 29,
2004
Balance – beginning of period $ 220,903   $ 254,361  
Provision for present value of noncancellable lease payments of stores closed   7,975     3,531  
Changes in assumptions about future sublease income, terminations and changes in interest rates   1,932     (10,973
Interest accretion   2,193     2,026  
Cash payments, net of sublease income   (9,123   (10,916
Balance – end of period $ 223,880   $ 238,029  

The Company's revenues and income from operations for the thirteen week periods ended May 28, 2005 and May 29, 2004 include results from stores that have been closed as of May 28, 2005. The revenue and operating losses of these stores for the periods are presented as follows:


  Thirteen Week Period Ended
  May 28,
2005
May 29,
2004
Revenues $ 10,381   $ 32,581  
Loss from operations   1,436     1,834  

Included in loss from operations for the thirteen weeks ended May 28, 2005, are depreciation and amortization charges of $64 and closed store liquidation charges of $1,646. Included in loss from operations for the thirteen weeks ended May 29, 2004, are depreciation and amortization charges of $284 and closed store liquidation charges of $1,686. The above results are not necessarily indicative of the impact that these closures will have on revenues and operating results of the Company in the future, as the Company often transfers the business of a closed store to another Company store, thereby retaining a portion of these revenues.

9




RITE AID CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
For the Thirteen Week Periods Ended May 28, 2005 and May 29, 2004
(Dollars and share information in thousands, except per share amounts)
(unaudited)

5.    Accounts Receivable

The Company maintains securitization agreements with several multi-seller asset-backed commercial paper vehicles. Under the terms of the securitization agreements, the Company sells substantially all of its eligible third party pharmaceutical receivables to a bankruptcy remote Special Purpose Entity (SPE) and retains servicing responsibility. The assets of the SPE are not available to satisfy the creditors of any other person, including any of the Company's affiliates. These agreements provide for the Company to sell, and for the SPE to purchase these receivables, and for the SPE to borrow funds secured by these receivables of up to $400,000. The amount of receivables funded at any one time is dependent upon a formula that takes into account such factors as default history, obligor concentrations and potential dilution. Adjustments to this amount can occur on a weekly basis. At May 28, 2005, proceeds from the sale of receivables to the SPE totaled $150,000. The average proceeds from the sale of receivables during the thirteen week period ended May 28, 2005 was $157,912. Receivables sold to the SPE for the thirteen week period ended May 28, 2005 totaled $2,007,108. Collections reinvested in securitizations amounted to $2,031,443 for the thirteen week period ended May 28, 2005. At May 28, 2005, the Company retained an interest in the third party pharmaceutical receivables in the form of overcollateralization of $402,098, which is included in accounts receivable, net, on the consolidated balance sheet at allocated cost, which approximates fair value. The securitization agreements did not exist during the thirteen week period ended May 29, 2004.

The Company must pay an ongoing program fee of approximately LIBOR plus 1.125% on the amount sold to the SPE under the securitization agreements and must pay a liquidity fee of 0.375% on the daily unused amount under the securitization agreements. The program and the liquidity fees are recorded as a component of selling, general and administrative expenses. Program and liquidity fees for the thirteen week period ended May 28, 2005 were $1,835. Rite Aid Corporation guarantees certain performance obligations of its affiliates under the securitization agreements, but does not guarantee the collectibility of the receivables and obligor creditworthiness.

The vehicles that make loans to the SPE have a commitment to lend that ends September 2005 with the option to annually extend the commitment to purchase. Should any of the vehicles fail to renew their commitment, the Company has access to a backstop credit facility, which is backed by the entities that make loans to the SPE's. The backstop facility is committed through September 2007.

Proceeds from the collections under the receivables securitization agreements are submitted to an independent trustee on a daily basis. The trustee withholds any cash necessary to fund overdraws on the facility and to pay trustee fees. The remaining collections are swept to the Company's corporate concentration account. At May 28, 2005, the Company has $1,235 of cash that is restricted for the payment of program and trustee fees.

The Company has concluded that the transactions meet the criteria for sales treatment in accordance with SFAS No. 140 "Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities". Additionally, the Company has concluded that consolidation is not appropriate in accordance with FIN 46R, "Consolidation of Variable Interest Entities."

6.    Sale Leaseback Transaction

On May 9, 2005, the Company sold the land and buildings on 9 owned stores to an independent third party. Proceeds from the sale were approximately $24,100. The Company entered into an agreement to lease the stores back from the purchaser over a minimum lease term of 20 years. The Company is accounting for 7 of the leases as operating leases. A gain related to sale of the 7 stores of approximately $3,800 has been deferred and is being recorded over the minimum lease term. The Company is accounting

10




RITE AID CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
For the Thirteen Week Periods Ended May 28, 2005 and May 29, 2004
(Dollars and share information in thousands, except per share amounts)
(unaudited)

for the remaining 2 leases as capital leases, as the lease agreements contain a clause that allows the buyer to force the Company to repurchase the property under certain conditions. The Company has recorded capital lease obligations of approximately $5,400 related to these leases. Future scheduled minimum payments under these leases for the remainder of fiscal 2006 and the succeeding four fiscal years are as follows: 2006-$1,616; 2007-$2,155; 2008-$2,155; 2009-$2,155; 2010-$2,155 and $35,021 in 2011 and thereafter.

7.    Goodwill and Other Intangibles

The Company accounts for goodwill under the guidance set forth in SFAS No. 142, which specifies that all goodwill and indefinite life intangibles shall not be amortized. Goodwill must be allocated to reporting units and evaluated for impairment on an annual basis. The Company completes its annual impairment evaluation at the end of its fiscal year. For the year ended February 26, 2005, the Company concluded that there was no goodwill impairment loss to be recognized. As of May 28, 2005, and February 26, 2005 the Company had goodwill of $684,535 and no indefinite life intangibles.

The Company's intangible assets other than goodwill are finite-lived and amortized over their useful lives. Following is a summary of the Company's intangible assets as of May 28, 2005 and February 26, 2005.


  May 28, 2005 February 26, 2005
  Gross
Carrying
Amount
Accumulated
Amortization
Weighted
Average
Amortization
Period
Gross
Carrying
Amount
Accumulated
Amortization
Weighted
Average
Amortization
Period
Favorable leases and other $ 308,456   $ (192,755 19 years $ 311,635   $ (191,482 20 years
Prescription files   374,715     (313,331 13 years   369,425     (310,098 13 years
Total $ 683,171   $ (506,086   $ 681,060   $ (501,580

Amortization expense for these intangible assets was $7,222 and $6,284, for the thirteen week periods ended May 28, 2005 and May 29, 2004, respectively. The anticipated annual amortization expense for these intangible assets is 2006 – $28,089, 2007 – $26,046, 2008 – $23,706, 2009 – $20,456 and 2010 – $15,940.

8.    Income Taxes

The Company recorded income tax expense of $13,911 for the thirteen week period ended May 28, 2005 and $5,049 for the thirteen week period ended May 29, 2004.

The provision for federal and state and local income taxes for the thirteen week period ended May 28, 2005 is net of the results from the receipt of a federal refund claim of $7,848 which related to the fiscal 2004 conclusion of the Internal Revenue Service examination for fiscal years 1996 through 2000.

The provision for income taxes for the thirteen week period ended May 29, 2004 is for state and local income taxes. The federal income tax expense was fully offset by utilization of net operating loss carryforwards resulting in the reduction of previously recorded valuation allowances.

The Company regularly evaluates valuation allowances established for deferred tax assets for which future realization is uncertain. The Company will continue to monitor all available evidence related to the remaining net deferred tax assets at least annually at the end of each fiscal year and at such time as events have occurred or are anticipated to occur that may change the most recent assessment. The estimation of required valuation allowances is based on a number of factors including the Company's historical operating performance and its expectation that it can generate sustainable consolidated taxable income

11




RITE AID CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
For the Thirteen Week Periods Ended May 28, 2005 and May 29, 2004
(Dollars and share information in thousands, except per share amounts)
(unaudited)

for the foreseeable future. As a result of the Company's operating performance in fiscal 2005 and the more favorable near term outlook for profitability, a portion of the valuation allowance was reduced in the fourth quarter of 2005. The Company continues to maintain a valuation allowance against remaining net deferred tax assets.

The Company has undergone an ownership change for statutory purposes during fiscal 2002, which resulted in a limitation on the future use of net operating loss carryforwards. The Company believes that this limitation does not further impair the net operating loss carryforwards.

9.    Indebtedness and Credit Agreements

General

Following is a summary of indebtedness and lease financing obligations at May 28, 2005 and February 26, 2005:


  May 28,
2005
February 26,
2005
Secured Debt:            
Senior secured credit facility due September 2009 $ 447,750   $ 448,875  
12.5% senior secured notes due September 2006 ($142,025 face value less unamortized discount of $2,209 and $2,599)   139,816     139,426  
8.125% senior secured notes due May 2010 ($360,000 face value less unamortized discount of $3,334 and $3,501)   356,666     356,499  
9.5% senior secured notes due February 2011   300,000     300,000  
7½% senior secured notes due January 2015   200,000     200,000  
Other   2,321     2,338  
    1,446,553     1,447,138  
Lease Financing Obligations   174,915     168,285  
Unsecured Debt:            
7.625% senior notes due April 2005       170,500  
6.0% fixed-rate senior notes due December 2005   38,047     38,047  
4.75% convertible notes due December 2006 ($250,000 face value less unamortized discount of $2,125 and $2,500)   247,875     247,500  
7.125% notes due January 2007   184,074     184,074  
11.25% senior notes due July 2008   150,000     150,000  
6.125% fixed-rate senior notes due December 2008   150,000     150,000  
9.25% senior notes due June 2013 ($150,000 face value less unamortized discount of $1,921 and $1,981)   148,079     148,019  
6.875% senior debentures due August 2013   184,773     184,773  
7.7% notes due February 2027   295,000     295,000  
6.875% fixed-rate senior notes due December 2028   128,000     128,000  
    1,525,848     1,695,913  
Total debt   3,147,316     3,311,336  
Current maturities of long-term debt and lease financing obligations   (52,258   (223,815
Long-term debt and lease financing obligations, less current maturities $ 3,095,058   $ 3,087,521  

12




RITE AID CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
For the Thirteen Week Periods Ended May 28, 2005 and May 29, 2004
(Dollars and share information in thousands, except per share amounts)
(unaudited)

Credit Facility

The senior secured credit facility consists of a $450,000 term loan and a $950,000 revolving credit facility which will mature in September 2009. Borrowings under the senior secured credit facility currently bear interest at LIBOR plus 1.75%, if the Company chooses to make LIBOR borrowings, or at Citibank's base rate plus 0.75%. The Company is required to pay fees of 0.375% per annum on the daily unused amount of the revolving credit facility. Amortization payments of $1,125 related to the term loan began on November 30, 2004 and will continue on a quarterly basis until May 31, 2009, with a final payment of $428,625 due August 31, 2009.

The senior secured credit facility allows for the issuance of up to $700,000 in additional term loans or additional revolver availability. The Company may request the additional loans at any time prior to the maturity of the senior secured credit facility, provided the Company is not in default of any terms of the facility, nor is the Company in violation of its financial covenants. The senior secured credit facility allows the Company to have outstanding, at any time, up to $1,800,000 in secured subordinated debt in addition to the senior secured credit facility (which amount is reduced by any additional unsecured debt that matures prior to December 31, 2009, as described below). The Company also has the ability to incur an unlimited amount of unsecured debt, if the debt does not mature or require scheduled payments of principal prior to December 31, 2009. The Company has the ability to incur additional unsecured debt of up to $200,000 with a scheduled maturity date prior to December 31, 2009. The maximum amount of additional secured subordinated debt and unsecured debt with a maturity prior to December 31, 2009 that can be incurred is $1,800,000. At May 28, 2005, remaining additional permitted secured subordinated debt under the senior secured credit facility was $797,975 in addition to what is available under the revolver; however, other debentures do not permit additional secured subordinated debt if the revolver is fully drawn. Subsequent to May 28, 2005, the Company called for the early redemption of its 11.25% senior notes due July 2008. Upon completion of this redemption, the Company will have the ability to incur additional secured subordinated debt of $234,725 under other debentures in addition to what is available under the revolving credit facility. The senior secured facility also allows for the repurchase of any debt with a maturity on or before September 22, 2009, and for the repurchase of debt with a maturity after September 22, 2009, if the Company maintains availability on the revolving credit facility of at least $300,000.

The senior secured credit facility contains customary covenants, which place restrictions on the incurrence of debt beyond the restrictions described above, the payments of dividends, mergers and acquisitions and the granting of liens. The senior secured credit facility also requires the Company to meet certain financial covenant ratios, but only if availability on the revolving credit facility is less then $300,000. If availability on the revolving credit facility had been less than $300,000, the covenants would have required the Company to maintain a maximum leverage ratio of 5.60:1 for the twelve months ended May 28, 2005. Subsequent to May 28, 2005, the ratio gradually decreases to 3.20:1 for the twelve months ended August 29, 2009. In addition, if the availability on the revolving credit facility had been less than $300,000, the Company would have been required to maintain a minimum fixed charge ratio of 1.05:1 for the twelve months ended May 28, 2005. Subsequent to May 28, 2005, the ratio gradually increases to 1.25:1 for the twelve months ending August 29, 2009.

The senior secured credit facility provides for customary events of default including nonpayments, misrepresentation, breach of covenants and bankruptcy. It is also an event of default if the Company fails to make any required payment on debt having a principal amount in excess of $25,000 or any event occurs that enables, or which with the giving of notice or the lapse of time would enable, the holder of such debt to accelerate the maturity of such debt.

The Company's ability to borrow under the senior credit facility is based upon a specified borrowing base consisting of inventory and prescription files. At May 28, 2005, the term loan was fully drawn and the

13




RITE AID CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
For the Thirteen Week Periods Ended May 28, 2005 and May 29, 2004
(Dollars and share information in thousands, except per share amounts)
(unaudited)

Company had no borrowings outstanding under the revolving credit facility. At May 28, 2005, the Company also had letters of credit outstanding against the revolving credit facility of $112,303, which gave the Company additional borrowing capacity of $837,697.

Other

On April 15, 2005 the Company paid at maturity the remaining outstanding principal amount of $170,500 of its 7.625% senior notes due April 2005.

The aggregate annual principal payments of long-term debt for the remainder of fiscal 2006 and the succeeding four fiscal years are as follows: 2006 – $42,918, 2007 – $576,701, 2008 – $5,132, 2009 – $304,829, 2010 – $429,869, and $1,612,952 in 2011 and thereafter. At May 28, 2005, the Company was in compliance with restrictions and limitations included in the provisions of various loan and credit agreements.

Substantially all of Rite Aid Corporation's wholly-owned subsidiaries guarantee the obligations under the senior secured credit facility. The subsidiary guarantees are secured by a first priority lien on, among other things the inventory, accounts receivable and prescription files of the subsidiary guarantors. Rite Aid Corporation is a holding company with no direct operations and is dependent upon dividends, distributions and other payments from its subsidiaries to service payments due under the senior secured credit facility. Rite Aid Corporation's direct obligations under the senior secured credit facility are unsecured. The 12.5% senior secured notes due 2006, the 9.5% senior secured notes due 2011, the 8.125% senior secured notes due 2010 and the 7½% senior secured notes due 2015 are guaranteed by substantially all of the Company's wholly-owned subsidiaries and are secured on a second priority basis by the same collateral as the senior secured credit facility.

The subsidiary guarantees related to the Company's senior secured credit facility and second priority bond issuances are full and unconditional and joint and several. Also, the parent company's assets and operations are not material and subsidiaries not guaranteeing the senior secured credit facility and bond issuances are minor. Accordingly, condensed consolidating financial information for the parent and subsidiaries is not presented.

10.    Retirement Plans

Net periodic pension expense recorded in the thirteen week periods ended May 28, 2005 and May 29, 2004, for the Company's defined benefit plans includes the following components:


  Defined Benefit
Pension Plan
Nonqualified Executive
Retirement Plan
  Thirteen Week Period Ended
  May 28,
2005
May 29,
2004
May 28,
2005
May 29,
2004
Service cost $ 687   $ 710   $ 19   $ 17  
Interest cost   1,176     1,200     305     246  
Expected return on plan assets   (539   (610        
Amortization of unrecognized net transition obligation           21     21  
Amortization of unrecognized prior service cost   123     175          
Amortization of unrecognized net loss   613     475     34     89  
Net pension expense $ 2,060   $ 1,950   $ 379   $ 373  

14




RITE AID CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
For the Thirteen Week Periods Ended May 28, 2005 and May 29, 2004
(Dollars and share information in thousands, except per share amounts)
(unaudited)

11.    Commitments and Contingencies

Legal Proceedings

Federal investigations

There are currently pending federal governmental investigations, both civil and criminal, by the United States Attorney, involving various matters related to prior management's business practices. The Company is cooperating fully with the United States Attorney. The Company has begun settlement discussions with the United States Attorney for the Middle District of Pennsylvania. The United States Attorney has proposed that the government would not institute any criminal proceeding against the Company if it enters into a consent judgment providing for a civil penalty payable over a period of years. The amount of the civil penalty has not been agreed to and there can be no assurance that a settlement will be reached or that the amount of such penalty will not have a material adverse effect on the Company's financial condition and results of operations. The Company has recorded an accrual of $20,000 in fiscal 2003 in connection with the resolution for these matters; however, the Company may incur charges in excess of that amount and is unable to estimate the possible range of loss. The Company will continue to evaluate its estimate and to the extent that additional information arises or its strategy changes, the Company will adjust the accrual accordingly.

These investigations and settlement discussions are ongoing and the Company cannot predict their outcomes. If the Company was convicted of any crime, certain licenses and government contracts such as Medicaid plan reimbursement agreements that are material to the Company's operations may be revoked, which would have a material adverse effect on the Company's results of operations, financial condition or cash flows. In addition, substantial penalties, damages or other monetary remedies assessed against the Company, including a settlement, could also have a material adverse effect on the Company's results of operations, financial condition or cash flows.

Other

In June 2000, the Company was sued by the Lemelson Foundation in a complaint which alleges that portions of the technology included in the Company's point-of-sale system infringe upon a patent held by the plaintiffs. The Lemelson Foundation has brought similar suit against a significant number of major U.S. retailers. The amount of damages sought is unspecified and may be material. Management cannot predict the outcome of this litigation or whether it could result in a material adverse effect on the Company's results of operations, financial conditions or cash flows.

The Company is subject from time to time to lawsuits arising in the ordinary course of business. In the opinion of the Company's management, these matters are adequately covered by insurance or, if not so covered are without merit or are of such nature or involve amounts that would not have a material adverse effect on its financial conditions, results of operations or cash flows if decided adversely.

12.    Subsequent Events

In June 2005, the Company called for the early redemption of all of its outstanding $150,000 aggregate principal amount of 11.25% senior notes due July 2008. The 11.25% senior notes will be redeemed on July 15, 2005 at their contractually determined early redemption price of 105.625% of the principal amount, plus accrued interest to the date of redemption. To fund this redemption, the Company plans to use one of or a combination of the following sources of funds: available cash on hand, its accounts receivable securitization agreements or its revolving credit facility. The Company expects to recognize a loss on debt retirement of approximately $9,100 in the second quarter of fiscal 2006 related to this transaction.

15




ITEM 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations

Overview

Net income for the thirteen week period ended May 28, 2005 was $33.4 million, compared to $63.7 million for the thirteen week period ended May 29, 2004. Our operating results have been impacted by a decline in revenues, an increase in selling, general and administrative ("SG&A") expenses, an increase in closed store charges and an increase in income tax expense, partially offset by improvements in gross margin rate and a reduction in interest expense. These items are described in further detail in the Results of Operations section below.

Sales Trends.    Our revenue decline for the thirteen weeks ended May 28, 2005 compared to the thirteen weeks ended May 29, 2004 was 0.5%. Factors effecting this decline are discussed more thoroughly in the Results of Operations section of this Item 2. A significant factor negatively impacting our revenue was the continuing penetration of mail order prescription programs, particularly the mandatory mail program that the United Auto Workers implemented between January and June 2004. We are taking steps to address this declining revenue trend by working to increase sales at our existing stores through improved customer service and developing new stores in our strongest markets. However, we expect our revenue results to continue to face significant pressures from the existing competitive environment.

Results Of Operations

Revenues and Other Operating Data


  Thirteen Week Period Ended
  May 28,
2005
May 29,
2004
  (dollars in thousands)
Revenues $ 4,221,436   $ 4,244,357  
Revenue (decrease) growth   (0.5 )%    4.9
Same store sales (decrease) growth   (0.3 )%    5.3
Pharmacy sales (decrease) growth   (1.5 )%    5.0
Same store pharmacy sales (decrease) growth   (1.2 )%    5.4
Pharmacy sales as a % of total sales   64.0   64.6
Third party sales as a % of total pharmacy sales   93.9   93.7
Front-end sales growth   0.9   4.7
Same store front-end sales growth   1.4   5.2
Front-end sales as a % of total sales   36.0   35.4
Store data:            
Total stores (beginning of period)   3,356     3,382  
New stores   2      
Closed stores   (5   (9
Store acquisitions, net   1     1  
Total stores (end of period)   3,354     3,374  
Remodeled stores   47     48  
Relocated stores   3     3  

Revenues

The 0.5% decline in revenue for the thirteen week period ended May 28, 2005, was driven by a decline in pharmacy sales of 1.5%, offset by front-end sales growth of 0.9%. The pharmacy decline is from a same store sales decrease of 1.2% for the thirteen week period ended May 28, 2005. This decrease is driven by an increase in generic sales mix, which sell for less than branded products but have higher margins, lower inflation and a decrease in the number of prescriptions filled. The decrease in the number of prescriptions filled is due primarily to certain third party payors requiring or encouraging customers to use mail order and safety concerns in hormone therapy, psychotherapeutic and antiarthritic prescriptions. Front-end sales growth is from a same store sales increase of 1.4% in the thirteen week period ended May 28, 2005, primarily as a result of improvements in over-the-counter, consumable and food products, partially offset by a decrease in photo and film and seasonal sales and decreased traffic in stores that were negatively impacted by mail order programs.

16




The 4.9% growth in revenues for the thirteen week period ended May 29, 2004, was driven by pharmacy sales growth of 5.0% and front end sales growth of 4.7%. The pharmacy sales growth is from a same store sales increase of 5.4% for the thirteen week period ended May 29, 2004, due to an increase in price per prescription. This increase was driven by inflation, and a shift in Memorial Day, partially offset by an increase in generic sales mix. Partially offsetting the increase in price per prescription was a slight decrease in the number of prescriptions filled, due primarily to the impact of a weaker cold and flu season, certain third party payors requiring customers to use mail order for certain prescriptions and a reduction in hormone therapy prescriptions. Front-end sales growth is from a same store sales increase of 5.2% in the thirteen week period ended May 29, 2004, primarily as a result of improvement in most core categories, such as over-the-counter items, consumables and vitamins, and improved assortments.

Pharmacy and front-end same store sales increases in the thirteen week period ended May 29, 2004, benefited from increased business in our Southern California stores, driven by the migration of customers impacted by a union strike at several grocery store chains. The union strike ended in March 2004.

We include in same store sales all stores that have been open at least one year. Stores in liquidation are considered closed. Relocated stores are included in same store sales.

Costs and Expenses


  Thirteen Week Period Ended
  May 28,
2005
May 29,
2004
  (dollars in thousands)
Cost of goods sold, including occupancy costs $ 3,140,803   $ 3,191,456  
Gross profit   1,080,633     1,052,901  
Gross margin   25.6   24.8
Selling, general and administrative expenses   947,453     912,845  
Selling, general and administrative expenses as a percentage of revenues   22.4   21.5
Store closing and impairment charges (credits)   15,532     (4,595
Interest expense   70,851     77,801  
Gain on sale of assets and investments, net   (538   (1,918

Cost of Goods Sold

Gross margin was 25.6% for the thirteen week period ended May 28, 2005, compared to 24.8% for the thirteen week period ended May 29, 2004. Gross margin was positively impacted by strong improvements in pharmacy margin, which was driven by improved generic product mix. Gross margin was also positively impacted by an increase in the ratio of front end sales to total sales, as front-end sales have a higher gross margin than pharmacy sales. Further, gross margin was positively impacted by lower expenses related to product returns and slow moving products and by lower LIFO related charges.

We use the last-in, first out (LIFO) method of inventory valuation, which is determined annually when inflation rates and inventory levels are finalized. Therefore, LIFO costs for interim period financial statements are estimated. Cost of sales include a LIFO provision of $7.6 million for the thirteen week period ended May 28, 2005 versus $10.7 million for the thirteen week period ended May 29, 2004.

Selling, General and Administrative Expenses

SG&A was 22.4% as a percentage of revenues for the thirteen week period ended May 28, 2005 compared to 21.5% for the thirteen week period ended May 29, 2004. The increase in SG&A as a percentage of revenues for the thirteen week period ended May 28, 2005 was due primarily to lower revenues and increases in pharmacy labor, increased benefit expenses, increased advertising expenses and increased repairs and maintenance expense. These increased expenses were partially offset by an increase in favorable litigation settlements.

17




Store Closing and Impairment Charges

Store closing and impairment (credits) charges consist of:


  Thirteen Week Period Ended
  May 28,
2005
May 29,
2004
  (dollars in thousands)
Impairment charges $ 3,457   $ 829  
Store and equipment lease exit charges (credits)   12,075     (5,424
  $ 15,532   $ (4,595

Impairment Charges:    Impairment charges include non-cash charges of $3.5 million and $0.8 million in the thirteen week periods ended May 28, 2005 and May 29, 2004, respectively, for the impairment of long-lived assets at 18 and 11 stores, in the respective periods. These amounts include the write-down of long-lived assets at stores that were assessed for impairment because of management's intention to relocate or close the store.

Store and Equipment Lease Exit Charges (Credits):    During the thirteen week periods ended May 28, 2005 and May 29, 2004, we recorded charges for five closed stores and one closed store in the respective periods. Charges to close a store, which principally consist of lease termination costs, are recorded at the time the store is closed and all inventory is liquidated, pursuant to the guidance set forth in SFAS No. 146, "Accounting for Costs Associated with Exit or Disposal Activities". We calculate our liability for closed stores on a store-by-store basis. The calculation includes the future minimum lease payments and related ancillary costs, from the date of closure to the end of the remaining lease term, net of estimated cost recoveries that may be achieved through subletting properties or through favorable lease terminations. This liability is discounted using a risk-free rate of interest. We evaluate these assumptions each quarter and adjust the liability accordingly. We recorded a closed store charge of $12.1 million in the thirteen week period ended May 28, 2005, due primarily to the charge recorded to close the five stores noted above and interest accretion. We recorded a net closed store credit of $5.4 million in the thirteen week period ended May 29, 2004, due primarily to the impact of adjustments to the risk-free rate of interest on the provision.

As part of our ongoing business activities, we assess stores for potential closure. Decisions to close stores in future periods would result in charges for store lease exit costs and liquidation of inventory, as well as impairment of assets at these stores.

Interest Expense

Interest expense was $70.9 million for the thirteen week period ended May 28, 2005, compared to $77.8 million for the thirteen week period ended May 29, 2004. The decrease in interest expense was due to a decrease in outstanding borrowings on and a lower interest rate from our senior secured credit facility. After taking into effect the July 2005 early redemption of our 11.25% senior notes due 2008, and assuming no further changes in our capital structure, we expect interest expense for the remainder of the year to be approximately $204.0 million. The weighted average interest rates, excluding capital leases, on our indebtedness for the thirteen week periods ended May 28, 2005 and May 29, 2004 were 7.5% and 6.8%, respectively.

Income Taxes

We regularly evaluate valuation allowances established for deferred tax assets for which future realization is uncertain. We will continue to monitor all available evidence related to our remaining net deferred tax assets at least annually at the end of each fiscal year and at such time as events have occurred or are anticipated to occur that may change our most recent assessment. The estimation of required valuation allowances is based on a number of factors including our historical operating performance and our expectation that we can generate sustainable consolidated taxable income for the foreseeable future. As a result of our operating performance in fiscal 2005 and the more favorable near term outlook for profitability, a portion of the valuation allowance was reduced in the fourth quarter of 2005. Should we

18




determine that it is more likely than not that we will realize additional deferred tax assets in the future, an additional adjustment would be required to reduce the existing valuation allowance.

The provision for federal and state and local income taxes for the thirteen week period ended May 28, 2005 is net of the results from the receipt of a federal refund claim of $7.8 million which related to the conclusion in fiscal 2004 of the Internal Revenue Service examination for fiscal years 1996 through 2000. We expect to pay minimal cash taxes for the foreseeable future as we have approximately $2.3 billion of net operating losses available to offset future taxable income.

The provision for income taxes for the thirteen week period ended May 29, 2004 is for state and local income taxes. The federal income tax expense was fully offset by utilization of net operating loss carryforwards resulting in the reduction of previously recorded valuation allowances.

Liquidity and Capital Resources

General

We have five primary sources of liquidity: (i) cash equivalent investments, (ii) cash provided by operating activities, (iii) the sale of accounts receivable under our securitization agreements, (iv) the revolving credit facility under our senior secured credit facility; and (v) sale-leasebacks of owned property. Our principal uses of cash are to provide working capital for operations, to service our obligations to pay interest and principal on debt, to provide funds for capital expenditures and to provide funds for repurchase of our publicly traded debt.

Credit Facility

Our senior secured credit facility consists of a $450.0 million term loan and a $950.0 million revolving credit facility which will mature in September 2009. Borrowings under the senior secured credit facility currently bear interest at LIBOR plus 1.75%, if we choose to make LIBOR borrowings, or at Citibank's base rate plus 0.75%. We are required to pay fees of 0.375% per annum on the daily unused amount of the revolving credit facility. Amortization payments of $1.1 million related to the term loan began on November 30, 2004 and will continue on a quarterly basis until May 31, 2009, with a final payment of $428.6 million due August 31, 2009.

Substantially all of our wholly-owned subsidiaries guarantee the obligations under the senior secured credit facility. The subsidiary guarantees are secured by a first priority lien on, among other things, the inventory, accounts receivable and prescription files of the subsidiary guarantors. Rite Aid Corporation is a holding company with no direct operations and is dependent upon dividends, distributions and other payments from its subsidiaries to service payments due under the senior credit facility. Rite Aid Corporation's direct obligations under the senior credit facility are unsecured.

The senior secured credit facility allows for the issuance of up to $700.0 million in additional term loans or additional revolver availability. We may request the additional loans at any time prior to the maturity of the senior secured credit facility, provided we are not in default of any terms of the facility, nor in violation of any of its financial covenants. The senior secured credit facility allows us to have outstanding, at any time, up to $1.8 billion secured subordinated debt in addition to the senior secured credit facility (which amount is reduced by any additional unsecured debt that matures prior to December 31, 2009, as described below). We also have the ability to incur an unlimited amount of unsecured debt, if the debt does not mature or require scheduled payments of principal prior to December 31, 2009. We have the ability to incur additional unsecured debt of up to $200.0 million with a scheduled maturity date prior to December 31, 2009. The maximum amount of additional secured subordinated debt and unsecured debt with a maturity prior to December 31, 2009 that can be incurred is $1.8 billion. At May 28, 2005, remaining additional permitted secured subordinated debt under the new senior secured credit facility is $798.0 million in addition to what is available under the revolver; however, other debentures do not permit additional secured subordinated debt if the revolver is fully drawn. Subsequent to May 28, 2005, we called for the early redemption of our 11.25% senior notes due July 2008. Upon completion of this redemption, we will have the ability to incur additional secured subordinated debt of $234.7 million

19




under other debentures in addition to what is available under the revolving credit facility. The senior secured facility also allows for the repurchase of any debt with a maturity on or before September 22, 2009, and for the repurchase of debt with a maturity after September 22, 2009, if we maintain availability on the revolving credit facility of at least $300.0 million.

The senior secured credit facility contains customary covenants, which place restrictions on the incurrence of debt beyond the restrictions described above, the payments of dividends, mergers and acquisitions and the granting of liens. The senior secured credit facility also requires us to meet certain financial covenant ratios, but only if availability on the revolving credit facility is less than $300.0 million. If availability on the revolving credit facility had been less than $300.0 million, the covenants would have required us to maintain a maximum leverage ratio of 5.60:1 for the twelve months ended May 28, 2005. Subsequent to May 28, 2005, the ratio gradually decreases to 3.20:1 for the twelve months ended August 29, 2009. In addition, if the availability on the revolving credit facility had been less than $300.0 million, we would have been required to maintain a minimum fixed charge ratio of 1.05:1 for the twelve months ended May 28, 2005. Subsequent to May 28, 2005, the ratio gradually increases to 1.25:1 for the twelve months ending August 29, 2009.

The senior secured credit facility provides for customary events of default including nonpayments, misrepresentation, breach of covenants and bankruptcy. It is also an event of default if we fail to make any required payment on debt having a principal amount in excess of $25.0 million or any event occurs that enables, or which with the giving of notice or the lapse of time would enable, the holder of such debt to accelerate the maturity of such debt.

Our ability to borrow under the senior credit facility is based upon a specified borrowing base consisting of inventory and prescription files. At May 28, 2005, the term loan was fully drawn and we had no borrowings outstanding under the revolving credit facility. At May 28, 2005, we also had letters of credit outstanding against the revolving credit facility of $112.3 million, which gave us additional borrowing capacity of $837.7 million at May 28, 2005.

Off Balance Sheet Obligations

We maintain receivables securitization agreements with several multi-seller asset-backed commercial paper vehicles. Under the terms of the securitization agreements, we sell substantially all of our eligible third party pharmaceutical receivables to a bankruptcy remote Special Purpose Entity (SPE) and retain servicing responsibility. The assets of the SPE are not available to satisfy the creditors of any other person, including any of our affiliates. These agreements provide for us to sell, and for the SPE to purchase these receivables, and for the SPE to borrow the funds secured by these receivables of up to $400.0 million. The amount of receivables funded at any one time is dependent upon a formula that takes into account such factors as default history, obligor concentrations and potential dilution. Adjustments to this amount can occur on a weekly basis. At May 28, 2005, proceeds from the sale of receivables to the SPE totaled $150.0 million. At May 28, 2005, we retained an interest in the third party pharmaceutical receivables in the form of overcollateralization of $402.1 million, which is included in accounts receivable, net, on the consolidated balance sheet at allocated cost, which approximates fair value.

We must pay an ongoing program fee of approximately LIBOR plus 1.125% on the amount sold to the SPE under the securitization agreements and must pay a liquidity fee of 0.375% on the daily unused amount under the securitization agreements. The program and the liquidity fees are recorded as a component of selling, general and administrative expenses. Rite Aid Corporation guarantees certain performance obligations of its affiliates under the securitization agreements, but does not guarantee the collectibility of the receivables and obligor creditworthiness.

The vehicles that make loans to the SPE have a commitment to lend that ends September 2005 with the option to annually extend the commitment to purchase. Should any of the vehicles fail to renew their commitment, we have access to a backstop credit facility, which is backed by the entities that make loans to the SPE's. The backstop facility is committed through September 2007.

As of May 28, 2005, we had no material off balance sheet arrangements, other than the receivables securitization agreements described above. Our contractual cash obligations and commitments, which

20




consist primarily of debt, capital and operating leases, open purchase orders, lease guarantees and outstanding letters of credit have not changed materially from the amounts disclosed in our Fiscal 2005 10-K.

Sale Leaseback Transaction

On May 9, 2005, we sold the land and buildings on 9 owned stores to an independent third party. Proceeds from the sale were $24.1 million. We entered into an agreement to lease the stores back from the purchaser over a minimum lease term of 20 years. We are accounting for 7 of the leases as operating leases. A gain related to sale of the 7 stores of $3.8 million has been deferred and is being recorded over the minimum lease term. We are accounting for the remaining 2 leases as capital leases, as the lease agreements contain a clause that allows the buyer to force us to repurchase the property under certain conditions. We have recorded capital lease obligations of $5.4 million related to these leases.

Other

In June 2005, we called for the early redemption of all of our outstanding $150.0 million aggregate principal amount of our 11.25% senior notes due July 2008. The 11.25% senior notes will be redeemed on July 15 at their contractually determined early redemption price of 105.625% of the principal amount, plus accrued interest. To fund this redemption, we plan to use one of or a combination of the following sources of funds: available cash on hand, our accounts receivable securitization agreements or our revolving credit facility.

The aggregate annual principal payments of long-term debt for the remainder of fiscal 2006, excluding the early redemption described above, and the succeeding four fiscal years are as follows: 2006-$42.9 million, 2007-$576.7 million, 2008-$5.1 million, 2009-$304.8 million, 2010-$429.9 million, and $1,613.0 million in 2011 and thereafter. At May 28, 2005 we were in compliance with restrictions and limitations included in the provisions of various loan and credit agreements.

Net Cash Provided by/Used in Operating, Investing and Financing Activities

Our operating activities provided $172.8 million of cash in the thirteen week period ended May 28, 2005 and provided $216.6 million of cash in the thirteen week period ended May 29, 2004. Operating cash flow for the thirteen week period ended May 28, 2005 was provided by net income of $33.4 million, net income tax refunds of $5.9 million, increases in accounts payables and decreases in accounts receivable, which offset $43.5 million in interest payments and increases in inventory. Operating cash flow for the thirteen week period ended May 29, 2004 was provided through net income of $63.7 million, income tax refunds of $36.0 million, increases in accounts payable and decreases in accounts receivable, which offset $52.2 million in interest payments and increases in inventory.

Cash used in investing activities was $22.1 million for the thirteen week period ended May 28, 2005 due to expenditures for property, plant and equipment and intangible assets, offset by proceeds from sale-leaseback transaction and proceeds from asset dispositions. Cash used in investing activities was $38.3 million for the thirteen week period ended May 29, 2004 due to expenditures for property, plant and equipment and intangible assets, offset by proceeds from asset dispositions.

Cash used in financing activities was $178.5 million for the thirteen week period ended May 28, 2005 due to the impact of scheduled debt payments, the change in zero balance cash accounts and preferred stock cash dividend payments. Cash used in financing activities was $12.8 million for the thirteen week period ended May 29, 2004, due to the impact of scheduled debt payments and the change in zero balance cash accounts.

Capital Expenditures

During the thirteen week period ended May 28, 2005, we spent $49.7 million on capital expenditures, consisting of $28.0 million related to new store construction, store relocation and store remodel projects, $13.7 million related to technology enhancements, improvements to distribution centers and other

21




corporate requirements and $8.0 million related to the purchase of prescription files from independent pharmacists. We plan to make total capital expenditures of approximately $350 to $400 million during fiscal 2006. These expenditures consist of approximately $235 to $250 million related to new store construction, store relocation and store remodel projects, $80 to $110 million dedicated to technology enhancements, improvements to distribution centers and other corporate requirements, and $35 to $40 million dedicated to the purchase of prescription files from independent pharmacies. Management expects that these capital expenditures will be financed primarily with cash flow from operations and proceeds from sale-leaseback transactions.

During the thirteen week period ended May 29, 2004, we spent $41.8 million on capital expenditures, consisting of $19.4 million related to new store construction, store relocation and other store construction projects and $22.4 million related to other store improvement activities and the purchase of prescription files from independent pharmacists.

Future Liquidity

We are highly leveraged. Our high level of indebtedness: (i) limits our ability to obtain additional financing; (ii) limits our flexibility in planning for, or reacting to, changes in our business and the industry; (iii) places us at a competitive disadvantage relative to our competitors with less debt; (iv) renders us more vulnerable to general adverse economic and industry conditions; and (v) requires us to dedicate a substantial portion of our cash flow to service our debt. Based upon current levels of operations and planned improvements in our operating performance, management believes that cash flow from operations together with cash equivalent investments, sales of accounts receivable under our securitization agreements and available borrowing under the senior secured credit facility and other sources of liquidity will be adequate to meet our anticipated annual requirements for working capital, debt service and capital expenditures through the end of fiscal 2006. We will continue to assess our liquidity position and potential sources of supplemental liquidity in light of our operating performance and other relevant circumstances. Should we determine, at any time, that it is necessary to seek additional short-term liquidity, we will evaluate our alternatives and take appropriate steps to obtain sufficient additional funds. The restrictions on the incurrence of additional indebtedness in our senior secured credit facility and several of our bond indentures may limit our ability to obtain additional funds. There can be no assurance that any such supplemental funding, if sought, could be obtained or, if obtained, would be on terms acceptable to us.

Recent Accounting Pronouncements

In December 2004, the Financial Accounting Standards Board ("FASB") issued SFAS No. 123R, "Shared-Based Payment". This Standard requires companies to account for share-based payments to associates using the fair value method of expense recognition. This standard is required to be adopted as of the first fiscal year beginning after June 15, 2005. We have not yet adopted SFAS No. 123R. However, as we have adopted the fair value recognition provisions of SFAS No. 123, we do not expect the adoption of SFAS No. 123R to have a material impact on our financial position or results of operations.

In March 2005, the FASB issued Interpretation No. 47 ("FIN 47"), "Accounting for Conditional Asset Retirement Obligations – an interpretation of FASB Statement No. 143". FIN 47 required an entity to recognize a liability for the fair value of a conditional asset retirement obligation if the fair value can be reasonably estimated. FIN 47 states that a conditional asset retirement obligation is a legal obligation to perform an asset retirement activity in which the timing or method of settlement are conditional upon a future event that may or may not be within control of the entity. FIN 47 is effective no later than the end of fiscal years ending after December 15, 2005. Retrospective application for the interim financial information is permitted but not required. Early adoption of FIN 47 is encouraged. We have not quantified the impact of adopting FIN 47, but do not expect the adoption to have a material impact on our financial position or results of operations.

Factors Affecting Our Future Prospects

For a discussion of risks related to our financial condition, operations and industry, refer to "Management's Discussion and Analysis of Financial Condition and Results of Operations—Overview" and "—Factors Affecting our Future Prospects" included in our Fiscal 2005 10-K.

22




ITEM 3.    Quantitative and Qualitative Disclosures About Market Risk

Our future earnings, cash flow and fair values relevant to financial instruments are dependent upon prevalent market rates. Market risk is the risk of loss from adverse changes in market prices and interest rates. The major market risk exposure is changing interest rates. Increases in interest rates would increase our interest expense. Since the end of fiscal 2005, our primary risk exposure has not changed. We enter into debt obligations to support capital expenditures, acquisitions, working capital needs and general corporate purposes. Our policy is to manage interest rates through the use of a combination of variable-rate credit facilities, fixed-rate long-term obligations and derivative transactions.

The table below provides information about our financial instruments that are sensitive to changes in interest rates. The table presents principal payments and the related weighted average interest rates by expected maturity dates as of May 28, 2005.


  2006 2007 2008 2009 2010 Thereafter Total Fair
Value
at May 28,
2005
  (dollars in thousands)
Long-term debt,
including current portion
                                               
Fixed rate $ 38,418   $ 572,201   $ 632   $ 300,329   $ 119   $ 1,612,952   $ 2,524,651   $ 2,350,198  
Average interest rate   6.02   7.48   8.00   8.69   8.00   7.65   8.01      
Variable rate   4,500     4,500     4,500     4,500     429,750         447,750     447,750  
Average interest rate   4.83   4.83   4.83   4.83   4.83   0.0   4.83      

As of May 28, 2005, 15.1% of our total debt is subject to fluctuations in variable interest rates.

Our ability to satisfy interest payment obligations on our outstanding debt will depend largely on our future performance, which, in turn, is subject to prevailing economic conditions and to financial, business and other factors beyond our control. If we do not have sufficient cash flow to service our interest payment obligations on our outstanding indebtedness and if we cannot borrow or obtain equity financing to satisfy those obligations, our business and results of operations will be materially adversely affected. We cannot assure you that any such borrowing or equity financing could be successfully completed.

In addition to the financial instruments listed above, the program fees incurred on proceeds from the sale of receivables under our receivables securitization agreements are determined based on LIBOR.

ITEM 4.    Controls and Procedures

(a) Disclosure Controls and Procedures.    Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this report. Our disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported accurately, and on a timely basis and to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, our disclosure controls and procedures are effective at the reasonable assurance level.

(b) Changes In Internal Control Over Financial Reporting.    There have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the most recent fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

23




PART II. OTHER INFORMATION

ITEM 1.    Legal Proceedings

Not Applicable.

ITEM 2.    Unregistered Sales of Equity Securities and Use of Proceeds

We have not sold any unregistered equity securities covered by this report, nor have we repurchased any equity securities during the period covered by this report.

ITEM 3.    Defaults Upon Senior Securities

Not applicable.

ITEM 4.    Submission of Matters to a Vote of Security Holders

No matters were submitted to a vote of the security holders during the thirteen week period ended May 28, 2005.

ITEM 5.    Other Information

Not applicable.

ITEM 6.    Exhibits

(a)    The following exhibits are filed as part of this report.


Exhibit
Numbers
Description Incorporation By
Reference To
  3.1   Restated Certificate of Incorporation dated December 12, 1996 Exhibit 3(i) to Form 8-K, filed on November 2, 1999
  3.2   Certificate of Amendment to the Restated Certificate of Incorporation dated February 22, 1999 Exhibit 3(ii) to Form 8-K, filed on November 2, 1999
  3.3   Certificate of Amendment to the Restated Certificate of Incorporation dated June 27, 2001 Exhibit 3.4 to Registration Statement on Form S-1, File No. 333-64950, filed on July 12, 2001
  3.4   7.0% Series E Mandatory Convertible Preferred Stock Certificate of Designation dated January 25, 2005 Exhibit 3.1 to Form 8-K, filed on
February 1, 2005
  3.5   8% Series F Cumulative Convertible Pay-in-Kind Preferred Stock Certificate of Designation dated January 28, 2005 Exhibit 3.1 to Form 8-K, filed on
February 2, 2005
  3.6   7% Series G Cumulative Convertible Pay-in-Kind Preferred Stock Certificate of Designation dated January 28, 2005 Exhibit 3.2 to Form 8-K, filed on
February 2, 2005
  3.7   6% Series H Cumulative Convertible Pay-in-Kind Preferred Stock Certificate of Designation dated January 28, 2005 Exhibit 3.3 to Form 8-K, filed on
February 2, 2005
  3.8   By-laws, as amended on November 8, 2000 Exhibit 3.1 to Form 8-K, filed on
November 13, 2000
  3.9   Amendment to By-laws, adopted January 30, 2002 Exhibit T3B.2 to Form T-3, filed on
March 4, 2002

24





Exhibit
Numbers
Description Incorporation By
Reference To
  4.1   Indenture, dated August 1, 1993 by and between Rite Aid Corporation, as issuer, and Morgan Guaranty Trust Company of New York, as trustee, related to the Company's 6.70% Notes due 2001, 7.125% Notes due 2007, 7.70% Debentures due 2027, 7.625% Senior Notes due 2005 and 6.875% Senior Debentures due 2013 Exhibit 4A to Registration Statement on Form S-3, File No. 033-63794, filed on June 3, 1993
  4.2   Supplemental Indenture dated as of February 3, 2000, between Rite Aid Corporation, as issuer, and U.S. Bank Trust National Association as successor to Morgan Guaranty Trust Company of New York, to the Indenture dated as of August 1, 1993, relating to the Company's 6.70%
Notes due 2001, 7.125% Notes due 2007, 7.70% Debentures due 2027, 7.625% Senior Notes due 2005 and 6.875% Senior Debentures due 2013
Exhibit 4.1 to Form 8-K filed on
February 7, 2000
  4.3   Indenture, dated as of December 21, 1998, between Rite Aid Corporation, as issuer, and Harris Trust and Savings Bank, as trustee,
related to the Company's 6% Notes due 2005, 6.125% Notes due 2008 and 6.875% Senior Debentures due 2028
Exhibit 4.1 to Registration Statement on Form S-4, File No. 333-74751, filed on March 19, 1999
  4.4   Supplemental Indenture, dated as of February 3, 2000, between Rite Aid Corporation and Harris Trust and Savings Bank, to the Indenture dated December 21, 1998, between Rite Aid Corporation and Harris Trust and Savings Bank, related to the Company's 6% Notes due 2005, 6.125% Notes due 2008 and 6.875% Senior Debentures due 2028 Exhibit 4.4 to Form 8-K, filed on
February 7, 2000
  4.5   Indenture, dated as of June 27, 2001, between Rite Aid Corporation, as issuer and State Street Bank and Trust Company, as trustee, related to
the Company's 12.50% Senior Secured Notes due 2006
Exhibit 4.7 to Registration Statement on Form S-1, File No. 333-64950, filed on July 12, 2001
  4.6   Indenture, dated as of June 27, 2001 between Rite Aid Corporation, as issuer and BNY Midwest Trust Company, as trustee, related to the Company's 11¼% Senior Notes due 2008 Exhibit 4.8 to Registration Statement on Form S-1, File No. 333-64950, filed on July 12, 2001
  4.7   Indenture, dated as of November 19, 2001, between Rite Aid Corporation, as issuer, and BNY Midwest Trust Company, as trustee,
related to the Company's 4.75% Convertible Notes due December 1, 2006
Exhibit 4.3 to Form 10-Q, filed on
January 15, 2002
  4.8   Indenture, dated as of February 12, 2003, between Rite Aid Corporation, as issuer, and BNY Midwest Trust Company, as trustee,
Related to the Company's 9½% Senior Secured Notes due 2011
Exhibit 4.1 to Form 8-K, filed on
March 5, 2003

25





Exhibit
Numbers
Description Incorporation By
Reference To
  4.9   Indenture, dated as of April 22, 2003, between Rite Aid Corporation, as issuer, and BNY Midwest Trust Company, as trustee, related to the Company's 8.125% Senior Secured Notes due 2010 Exhibit 4.11 to Form 10-K, filed on
May 2, 2003
  4.10   Indenture, dated as of May 20, 2003, between Rite Aid Corporation, as issuer, and BNY Midwest Trust Company, as trustee, related to the Company's 9.25% Senior Notes due 2013 Exhibit 4.12 to Form 10-Q, filed on July 3, 2003
  4.11   Indenture, dated as of January 11, 2005, among the Company, the subsidiary guarantors described therein, and BNY Midwest Trust Company, as Trustee, related to the Company's 7.5% Senior Secured Notes due January 15, 2005 Exhibit 99.2 to Form 8-K, filed on
January 13, 2005
  11   Statement regarding computation of earnings per share. (See Note 3 to the condensed consolidated financial statements) Filed herewith
  31.1   Certification of CEO pursuant to Rule 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934. Filed herewith
  31.2   Certification of CFO pursuant to Rule 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934. Filed herewith
  32   Certification of CEO and CFO pursuant to 18 United States Code, Section 1350, as adopted persuant to Section 906 of the Sarbanes-Oxley Act of 2002 Filed herewith

26




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Date: June 30, 2005 RITE AID CORPORATION
  By: /s/ ROBERT B. SARI
  Robert B. Sari
Senior Vice President and General Counsel
Date: June 30, 2005 By: /s/ JOHN T. STANDLEY
  John T. Standley
Senior Executive Vice President,
Chief Administrative Officer, and
Chief Financial Officer

27